EQUINEXT
Equinext, LLC develops technologies for the treatment of ligament and tendon injuries in horses in the United States. It offers nonsurgical exogenous crosslink therapy (NEXT), a chemically made device formed following injection of a crosslinking agent into the lesion of the tendon or ligament that interacts with the native proteins (collagen). The company’s products are also used to treat the causes of wobbler’s disease and intervertebral disc degradation. It has strategic partnership with Hagyard Equine Medical Institute. The company was incorporated in 2011 and is based in Lexington, Kentucky.
EQUINEXT
Industry:
Hardware
Founded:
2011-01-01
Address:
Lexington, Kentucky, United States
Country:
United States
Website Url:
http://www.equinext.net
Total Employee:
1+
Status:
Closed
Contact:
866.348.1991
Email Addresses:
[email protected]
Total Funding:
985 K USD
Technology used in webpage:
SPF Amazon Google Apps For Business GoDaddy DNS AWS Global Accelerator
Current Employees Featured
Founder
Investors List
Keyhorse Capital (KSTC)
Keyhorse Capital (KSTC) investment in Seed Round - Equinext
Official Site Inspections
http://www.equinext.net
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
